FDA Approves Bicillin C-R (penicillin G benzathine and procaine) for Streptococcal and Pneumococcal Infections
FDA approves new antibiotic Bicillin C-R for certain infections.
The FDA approved Bicillin C-R, a combination of penicillin G benzathine and penicillin G procaine, for moderately severe infections due to s…
The FDA approved Bicillin C-R, a combination penicillin antibiotic, for adults and children with certain bacterial infections like strep thr…
FDA Approves Bicillin L-A (penicillin G benzathine) for Streptococcal Infections and Syphilis
FDA approves Bicillin L-A for certain bacterial infections and prevention.
The FDA approved Bicillin L-A (penicillin G benzathine) for mild-to-moderate upper respiratory streptococcal infections, venereal infections…
The FDA approved Bicillin L-A (penicillin G benzathine) for treating mild-to-moderate infections like strep throat and syphilis, and for pre…
FDA Approves Arikayce (amikacin liposome inhalation suspension) for Refractory MAC Lung Disease
FDA approves new drug Arikayce for hard to treat lung infection.
FDA approved Arikayce for treatment of Mycobacterium avium complex (MAC) lung disease in adults with limited or no alternative options, as p…
The FDA approved Arikayce (amikacin liposome inhalation suspension) for adults with a stubborn lung infection called MAC lung disease. It is…
FDA Approves Zevtera (ceftobiprole) for Staphylococcus aureus Bloodstream Infections, ABSSSI, and CABP
FDA approves new antibiotic Zevtera for serious bacterial infections.
The FDA approved Zevtera (ceftobiprole) for adult patients with Staphylococcus aureus bloodstream infections (including right-sided infectiv…
The FDA approved Zevtera (ceftobiprole) to treat Staphylococcus aureus bloodstream infections, including endocarditis, skin infections, and …
Ensitrelvir improves viral clearance and reduces viral RNA in patients with mild-to-moderate COVID-19
Ensitrelvir helps clear the virus in mild to moderate COVID-19
This meta-analysis of 2,890 patients found that Ensitrelvir (125 mg or 250 mg) significantly improved viral clearance and reduced viral RNA …
New data shows that Ensitrelvir can help patients with mild to moderate COVID-19 clear the virus from their systems more quickly.
Intralesional human papillomavirus vaccination significantly increases complete clearance of persistent cutaneous warts
Intralesional HPV Vaccination Shows Promise for Clearing Cutaneous Warts
This systematic review and meta-analysis of 6 studies evaluates intralesional HPV vaccination for patients with chronic or persistent cutane…
A new analysis suggests that injecting the HPV vaccine directly into skin warts may significantly improve clearance rates compared to saline…
HBeAg seroclearance in HBeAg-positive chronic hepatitis B correlates with disease remission and reduced hepatocellular carcinoma risk
Clearing HBeAg helps manage chronic hepatitis B and liver risk
This systematic review examines the clinical significance and optimization strategies of HBeAg seroclearance in patients with HBeAg-positive…
Achieving HBeAg seroclearance in patients with chronic hepatitis B can lead to disease remission and a lower risk of developing liver cancer…
Klebsiella pneumoniae shows 44% pooled prevalence of antibiotic resistance in Burkina Faso healthcare settings
Antibiotic-resistant Klebsiella pneumoniae found in 44% of Burkina Faso cases
This systematic review and meta-analysis evaluates the phenotypic and molecular resistance of Klebsiella pneumoniae in healthcare settings i…
A new analysis finds 44% of Klebsiella pneumoniae infections in Burkina Faso hospitals resist antibiotics, with 85% resistant to penicillin.
6-month bedaquiline, linezolid, delamanid, and levofloxacin or clofazimine regimen is noninferior to 9-month standard care
Trial shows shorter treatment works for resistant tuberculosis
This Phase 3 randomized controlled noninferiority trial evaluated a 6-month treatment strategy for pulmonary rifampicin-resistant tuberculos…
A new six-month treatment plan for drug-resistant tuberculosis showed similar success rates to the standard nine-month course.
Doravirine and islatravir combination shows reduced virological failure risk in adults with HIV-1
Trial shows doravirine and islatravir reduce HIV-1 treatment failure
This meta-analysis evaluated the efficacy of a doravirine and islatravir regimen compared to standard triple option therapy for patients liv…
A new two-drug combination for HIV-1 shows a significantly lower risk of treatment failure compared to standard triple therapy.
Berberine reduces weight, lipids in schizophrenia with metabolic syndrome: meta-analysis
Berberine may improve weight and cholesterol in schizophrenia patients
This meta-analysis of 3 RCTs (233 patients) found that adjunctive berberine significantly reduced body weight, BMI, waist circumference, tot…
Adding berberine to treatment could help people with schizophrenia manage weight, waist size, and cholesterol levels.
Climate change drives increased frequency of vector-borne diseases through expansion of endemic areas
Climate change increases risk of heart and respiratory diseases
This narrative review synthesizes the public health consequences of global warming and climate change. The authors argue that rising tempera…
Rising global temperatures are expanding the reach of infectious diseases and creating new risks for heart, lung, and mental health.